Epilepsy drug maker Zogenix soars on UCB's potential $2 bln deal
Jan 19 (Reuters) - Shares of Zogenix Inc soared more than 60% on Wednesday after Belgium's UCB SA agreed to buy the U.S. drugmaker in a deal worth up to...
Jan 19 (Reuters) - Shares of Zogenix Inc soared more than 60% on Wednesday after Belgium's UCB SA agreed to buy the U.S. drugmaker in a deal worth up to...